anti-cancer drug design[ta] - Search Results

Year	Number of Results
1985	6
1986	20
1987	36
1988	28
1989	29
1990	39
1991	34
1992	38
1993	33
1994	41
1995	45
1996	43
1997	51
1998	60
1999	51
2000	48
2001	33
2024	0

1

Telomerase as an anti-cancer drug target: will it fulfil its early promise?

Newbold RF. Newbold RF. Anticancer Drug Des. 1999 Aug;14(4):349-54. Anticancer Drug Des. 1999. PMID: 10625927 Review.

2

Inhibition of Ras prenylation: a signaling target for novel anti-cancer drug design.

Lerner EC, Hamilton AD, Sebti SM. Lerner EC, et al. Anticancer Drug Des. 1997 Jun;12(4):229-38. Anticancer Drug Des. 1997. PMID: 9199657 Review.

3

The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets.

Monks A, Scudiero DA, Johnson GS, Paull KD, Sausville EA. Monks A, et al. Anticancer Drug Des. 1997 Oct;12(7):533-41. Anticancer Drug Des. 1997. PMID: 9365500 Review. No abstract available.

4

DNA topoisomerase II as the primary target of anti-tumor anthracyclines.

Zunino F, Capranico G. Zunino F, et al. Anticancer Drug Des. 1990 Nov;5(4):307-17. Anticancer Drug Des. 1990. PMID: 1963303 Review.

5

Structure-based design of potent inhibitors of EGF-receptor tyrosine kinase as anti-cancer agents.

Ghosh S, Narla RK, Zheng Y, Liu XP, Jun X, Mao C, Sudbeck EA, Uckun FM. Ghosh S, et al. Anticancer Drug Des. 1999 Oct;14(5):403-10. Anticancer Drug Des. 1999. PMID: 10766295

6

UCN-01 (7-hydroxystaurosporine) and other indolocarbazole compounds: a new generation of anti-cancer agents for the new century?

Akinaga S, Sugiyama K, Akiyama T. Akinaga S, et al. Anticancer Drug Des. 2000 Feb;15(1):43-52. Anticancer Drug Des. 2000. PMID: 10888035 Review.

7

Application of combinatorial library methods in cancer research and drug discovery.

Lam KS. Lam KS. Anticancer Drug Des. 1997 Apr;12(3):145-67. Anticancer Drug Des. 1997. PMID: 9154108 Review.

8

Investigations on the biological properties of the lipophilic DHFR-inhibitory benzoprims reveal non-folate modes of action and opportunities for anti-cancer drug design.

Croughton KA, Matthews CS, Griffin RJ, Stevens MF. Croughton KA, et al. Anticancer Drug Des. 2001 Apr-Jun;16(2-3):119-28. Anticancer Drug Des. 2001. PMID: 11962509

9

The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?

McCluskey A, Ackland SP, Gardiner E, Walkom CC, Sakoff JA. McCluskey A, et al. Anticancer Drug Des. 2001 Dec;16(6):291-303. Anticancer Drug Des. 2001. PMID: 12375882

10

Telomerase as an anti-cancer target: current status and future prospects.

Neidle S, Kelland LR. Neidle S, et al. Anticancer Drug Des. 1999 Aug;14(4):341-7. Anticancer Drug Des. 1999. PMID: 10625926 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

635 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

635 results

Results by year